Prostate cancer patients with rising PSA whilst on first-line androgen deprivation therapy ( ADT ) were randomised ( @:@ ) in a double-blind trial to receive bicalutamide @mg plus placebo or bicalutamide @mg plus dutasteride @ mg once daily for @ months .